// App-Quantinova.ai

9075 : Randomized, double-blind, placebo-controlled trial of evofosfamide (Evo) and pemetrexed (Pem) in advanced non-squamous non-small cell lung cancer (n-s NSCLC).

Researchers

Presenter

  • Tibor Csoszi

Principal Investigators

  • Jonathan Wade Goldman

  • Maria Szilasi

  • Joachim Von Pawel

  • Silvia Novello

  • Corey Allan Carter

  • Tudor-Eliade Ciuleanu

  • Alessandro Del Conte

  • Gurkamal Chatta

  • Michael Schenker

  • Francisco Robert

  • Sergey Orlov

  • Katarzyna Zajda

  • Filippo De Marinis

  • Charles L. Bennett

  • Stew Kroll

  • Tillman E. Pearce

  • Chandra Belani

Medical Centers

  • Jasz-Nagykun Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Hungary

  • UCLA and the Jonsson Comprehensive Cancer Center, Los Angeles, CA

  • University of Debrecen Medical and Health Science Center, Debrecen 4032, Hungary

  • Pneumology Clinic, Asklepios Fachkliniken, Gauting, Germany

  • Azienda Ospedaliero-Universitaria S. Luigi Gonzaga, Orbassano, Italy

  • Walter Reed National Military Medical Center, Washington, DC

  • Chiricuta Institute of Oncology, Cluj County, Romania

  • Azienda Ospedaliera "Santa Maria degli Angeli", Pordenone, Italy

  • Virginia Mason Cancer Institute, Seattle, WA

  • Sf Nectarie Oncology Center Craiova, Craiova, Romania

  • The University of Alabama Birmingham Comprehensive Cancer Center, Birmingham, AL

  • Department of Thoracic Oncology, St. Petersburg State Medical University, St. Petersburg, Russia

  • Maria Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland

  • IEO, Milan, Italy

  • University of South Carolina College of Pharmacy, Columbia, SC

  • Threshold Pharmaceuticals, Inc., South San Francisco, CA

  • Penn State Cancer Institute, Hershey, PA

Locations

  • Italy

  • Poland

  • Germany

  • United States

  • Russia

  • Romania

  • Hungary

Companies

  • Threshold Pharmaceut

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Evofosfamide

  • Pemetrexed

Outcome

  • Unknown

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multinational

  • Multicenteric

  • Controlled

Phase

  • I/II

Study Id's

  • NCT02093962

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved